New approaches to the treatment of non-Hodgkin's lymphoma.
D000912:Antibodies, Neoplasm; D001402:B-Lymphocytes / Q000276:immunology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000378:metabolism; D004317:Doxorubicin / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007167:Immunotherapy; D002955:Leucovorin / Q000627:therapeutic use; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D008727:Methotrexate / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
D000912:Antibodies, Neoplasm; D004273:DNA, Neoplasm; D004317:Doxorubicin; D003520:Cyclophosphamide; D002955:Leucovorin; D008727:Methotrexate